Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (561-570 of 594) with videos related to

Pageof 60
Sort By:
Cancers|December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung CancerHui Li, Lingzhi Hong, Pedro Rocha, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine CarcinomaMinglei Zhuo, Yanfang Guan, Xue Yang, et al.
Cancer Discovery|July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical RecurrenceAlexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Nature Communications|April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insightsSheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.
Nature Communications|May 12, 2021
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular featuresHitoshi Dejima, Xin Hu, Runzhe Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Nature Communications|February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancerLingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Cell Reports. Medicine|March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of conceptMorteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Pageof 60

Showing results (561-570 of 594) with videos related to

Sort By:
Pageof 60
Cancers|December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung CancerHui Li, Lingzhi Hong, Pedro Rocha, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine CarcinomaMinglei Zhuo, Yanfang Guan, Xue Yang, et al.
Cancer Discovery|July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical RecurrenceAlexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Nature Communications|April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insightsSheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.
Nature Communications|May 12, 2021
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular featuresHitoshi Dejima, Xin Hu, Runzhe Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Nature Communications|February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancerLingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Cell Reports. Medicine|March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of conceptMorteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Pageof 60